Stokes Family Office, LLC Eli Lilly & CO Transaction History

Stokes Family Office, LLC

$883 Million
Q3 2024

A detailed history of Stokes Family Office, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stokes Family Office, LLC holds 4,256 shares of LLY stock, worth $3.39 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

4,256

Previous 4,306 1.16%

Holding current value

$3.39 Million

Previous $3.9 Million 3.28%

% of portfolio

0.43%

Previous 0.47%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $38,607 - $48,001	-50 Reduced 1.16%	4,256 $3.77 Million
Q2 2024 Jul 05, 2024	BUY	$724.87 - $909.04 $278,350 - $349,071	384 Added 9.79%	4,306 $3.9 Million
Q1 2024 May 06, 2024	SELL	$592.2 - $792.28 $136,798 - $183,016	-231 Reduced 5.56%	3,922 $3.05 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $379,187 - $447,011	-722 Reduced 14.81%	4,153 $2.42 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $106,501 - $146,828	245 Added 5.29%	4,875 $2.62 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $9,119 - $12,193	-26 Reduced 0.56%	4,630 $2.17 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $47,526 - $55,817	-153 Reduced 3.18%	4,656 $1.6 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $124,118 - $144,622	386 Added 8.73%	4,809 $1.76 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $35,874 - $40,882	121 Added 2.81%	4,423 $1.43 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $27,315 - $32,072	98 Added 2.33%	4,302 $1.4 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $60,550 - $75,248	-258 Reduced 5.78%	4,204 $1.2 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $14,390 - $17,858	64 Added 1.46%	4,462 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $9,085 - $11,181	41 Added 0.94%	4,398 $1.02 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $23,110 - $29,893	128 Added 3.03%	4,357 $1 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $17,089 - $22,122	104 Added 2.52%	4,229 $789,000
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $63,664 - $84,243	488 Added 13.42%	4,125 $697,000
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $25,588 - $29,597	175 Added 5.05%	3,637 $538,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $12,414 - $14,940	-91 Reduced 2.56%	3,462 $568,000
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $2,857 - $3,536	24 Added 0.68%	3,553 $493,000
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $377,320 - $467,345	3,529 New	3,529 $464,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.

Account

Stokes Family Office, LLC Eli Lilly & CO Transaction History